FRANCISCO
CASQUERO OCIO
Investigador hasta 2022
Pedro
Bilbao Zulaica
Publicaciones en las que colabora con Pedro Bilbao Zulaica (20)
2019
-
Are there enough radiation oncologists to lead the new Spanish radiotherapy?
Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1663-1672
-
Late toxicity after single dose HDR prostate brachytherapy and EBRT for localized prostate cancer: Clinical and dosimetric predictors in a prospective cohort study
Radiotherapy and Oncology, Vol. 135, pp. 13-18
-
Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT
European Journal of Cancer Care, Vol. 28, Núm. 5
2018
-
Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter?
Journal of Medical Imaging and Radiation Oncology, Vol. 62, Núm. 4, pp. 578-584
-
Health-related-quality-of-life and toxicity after single fraction 19 Gy high-dose-rate prostate brachytherapy: Phase II trial
Radiotherapy and Oncology, Vol. 126, Núm. 2, pp. 278-282
-
Infrastructure and equipment for radiation oncology in the Spanish National Health System: analysis of external beam radiotherapy 2015–2020
Clinical and Translational Oncology, Vol. 20, Núm. 3, pp. 402-410
-
Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate Cancer
International Journal of Radiation Oncology Biology Physics, Vol. 101, Núm. 5, pp. 1172-1178
2017
-
Transperineal biopsies of MRI-detected aggressive index lesions in low- and intermediate-risk prostate cancer patients: Implications for treatment decision
Brachytherapy, Vol. 16, Núm. 1, pp. 201-206
2016
-
Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trial
Radiotherapy and Oncology, Vol. 119, Núm. 1, pp. 91-96
-
Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: The point of view of the radiation oncologist
British Journal of Radiology, Vol. 89, Núm. 1067
-
Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy
Journal of Contemporary Brachytherapy, Vol. 8, Núm. 6, pp. 477-483
2015
-
Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: Multicenter prospective observational study
BMC Palliative Care, Vol. 14, Núm. 1
2014
-
A prospective analysis of factors that influence weight loss in patients undergoing radiotherapy
Chinese Journal of Cancer, Vol. 33, Núm. 4, pp. 204-210
-
A prospective analysis of inter- and intrafractional errors to calculate CTV to PTV margins in head and neck patients
Clinical and Translational Oncology, Vol. 17, Núm. 2, pp. 113-120
-
Impact of intraoperative MRI/TRUS fusion on dosimetric parameters in cT3a prostate cancer patients treated with high-dose-rate real-time brachytherapy
Journal of Contemporary Brachytherapy, Vol. 6, Núm. 2, pp. 154-160
-
The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach
Cancer Treatment Reviews, Vol. 40, Núm. 1, pp. 178-189
2013
-
Definitive radiotherapy for T1 glottic squamous cell carcinoma: A 15-year Cruces University Hospital experience
Clinical and Translational Oncology, Vol. 15, Núm. 11, pp. 925-931
2012
-
Detection of risk factors that influence weight loss in patients undergoing radiotherapy
Reports of Practical Oncology and Radiotherapy, Vol. 17, Núm. 5, pp. 269-275
-
Smartphones and tablets: Reshaping radiation oncologists' lives
Reports of Practical Oncology and Radiotherapy, Vol. 17, Núm. 5, pp. 276-280
2000
-
Cáncer de Mama. Tratamiento Radioterápico
Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 97, Núm. 3, pp. 79-82